ALT Altimmune, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 12, 2026
$2,74
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$2,56minimo 52 sett.
$6,44massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$532M
P/E
-2.7
EPS
$-1.00
Ricavi
$41.0K
i tuoi badge
Intervallo 52 sett.
$3–$6
Rating Analisti
BUY
Prezzo Obiettivo
$17
P/E
-2.7
ROE
-45.6%
Margine di Profitto Netto
-214861.0%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
ALT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$2.73
Capitalizzazione di Mercato (MRQ)
$532M
P/E
-2.7
EPS
$-1.00
Ricavi
$41.0K
ROE
-45.6%
D/E Debito/Patrimonio (MRQ)
0.1
Intervallo 52 sett.
$3–$6
ALT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 14 Settembre 2018 | 1-for-30 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$41.0K2016-12-31 → 2025-12-31
EPS$-1.002016-12-31 → 2025-12-31
Flusso di cassa libero$-68M2016-12-31 → 2025-12-31
Margine netto-214861.0%2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | ALT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -2.7media 5 anni ≈-5.8 | ≈-5.8 | · | · | |
| P/S | 7396.7media 5 anni ≈5179.2 | ≈5179.2 | 144.0 | Sopravvalutato | |
| P/B (MRQ) | 1.1media 5 anni ≈3.3 | ≈3.3 | 3.1 | Sottovalutato | |
| EV / EBITDA | -0.7media 5 anni ≈-3.6 | ≈-3.6 | · | · | |
| Prezzo / FCF (TTM) | -6.9media 5 anni ≈-8.4 | ≈-8.4 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -7.0media 5 anni ≈-8.1 | ≈-8.1 | · | · | |
| EV / Revenue (EV / Ricavi) | 1563.3media 5 anni ≈-1759.5 | ≈-1759.5 | · | · | |
| EV / FCF (TTM) | -3.1media 5 anni ≈-4.8 | ≈-4.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 1.3media 5 anni ≈3.4 | ≈3.4 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | ALT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -230461.0%media 5 anni ≈-128401.5% | ≈-128401.5% | -2083.6% | Debole | |
| EBITDA Margin (Margine EBITDA) | -230461.0%media 5 anni ≈-128338.7% | ≈-128338.7% | -2083.6% | Debole | |
| Pretax Margin (Margine ante imposte) | -216522.0%media 5 anni ≈-117982.6% | ≈-117982.6% | -8123.7% | Debole | |
| Net Profit Margin (Margine di Profitto Netto) | -214861.0%media 5 anni ≈-117708.3% | ≈-117708.3% | -1978.2% | Debole | |
| ROA | -42.0%media 5 anni ≈-44.1% | ≈-44.1% | -38.2% | Debole | |
| ROE | -45.6%media 5 anni ≈-52.4% | ≈-52.4% | -43.9% | In linea | |
| ROIC | -36.2% | · | -36.2% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | ALT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.1media 5 anni ≈0.1 | ≈0.1 | · | · | |
| Rapporto corrente (MRQ) | 26.8media 5 anni ≈14.3 | ≈14.3 | 13.8 | Liquidità elevata | |
| Quick Ratio | 18.2media 5 anni ≈13.7 | ≈13.7 | 7.0 | Liquidità elevata | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.1media 5 anni ≈0.1 | ≈0.1 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | ALT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 105.0%media 5 anni ≈-12.1% | ≈-12.1% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -83.5% | · | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -65.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | ALT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.0 | In linea | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$719.30 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
17.3%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 12, 2026 | $-0.12 | $-0.14 | 14.2% |
| 31 Marzo 2026 | Mag 13, 2026 | $-0.18 | $-0.25 | 27.4% |
| 31 Dicembre 2025 | $-0.27 | $-0.25 | -10.2% | |
| 30 Settembre 2025 | $-0.21 | $-0.28 | 26.1% | |
| 30 Giugno 2025 | $-0.27 | $-0.33 | 17.2% | |
| 31 Marzo 2025 | $-0.26 | $-0.37 | 29.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| R&D Expense | $66M | $82M | $66M | $71M | $75M | $50M | $18M | $18M | $18M | $7M | $5M | $9M | |
| SG&A Expense | $28M | $21M | $18M | $17M | $15M | $13M | $9M | $10M | $8M | $7M | $6M | $11M | |
| Operating Expenses | $95M | $103M | $96M | $88M | $101M | $63M | $27M | $53M | $63M | $14M | $14M | $20M | |
| Operating Income | $-94M | $-103M | $-96M | $-88M | $-97M | $-55M | $-21M | $-43M | $-52M | $-11M | $-3M | $-10M | |
| Interest Expense | · | · | $35.0K | $8.0K | $5.0K | $9.4K | $2.2K | $297.1K | $162.1K | $38.5K | $54.6K | $210.4K | |
| Interest Income | $8M | $8M | $7M | $3M | $203.0K | $322.5K | $843.4K | $226.6K | $47.6K | $1.0K | · | · | |
| Other Non-op | $-190.0K | $48.0K | $166.0K | $-32.0K | $-374.0K | $24.1K | $15.1K | $277.9K | $5.7K | $42.3K | $8.1K | $-762 | |
| Pretax Income | $-89M | $-95M | $-88M | $-85M | $-97M | $-54M | $-21M | $-45M | $-52M | $-11M | $-3M | $-10M | |
| Income Tax | $-681.0K | · | · | $-197.0K | · | $-5M | $-58.5K | $-6M | $-6M | $0 | $61.7K | $61.7K | |
| Net Income | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| EPS (Basic) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.97 | $-0.05 | $-0.17 | |
| EPS (Diluted) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.95 | $-0.05 | $-0.17 | |
| Shares (Basic) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,306,962 | 63,986,013 | 57,535,325 | |
| Shares (Diluted) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,657,802 | 63,986,013 | 57,535,325 | |
| EBITDA | $-94M | $-103M | $-96M | $-88M | $-96M | $-55M | $-21M | $-43M | · | $-11M | $-3M | $-10M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $37M | $135M | $111M | $190M | $116M | $9M | $34M | $9M | $3M | $16M | $19M | |
| Short-term Investments | $230M | $95M | $63M | $74M | · | $100M | $28M | · | · | $67M | $0 | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Prepaid Expense | $3M | $2M | $7M | $5M | $8M | $2M | $470.2K | $548.1K | $994.3K | $420.4K | $181.7K | $199.2K | |
| Current Assets | $278M | $137M | $210M | $193M | $204M | $230M | $39M | $39M | $23M | $4M | $17M | $19M | |
| PP&E (Net) | $312.0K | $413.0K | $651.0K | $1M | $1M | $1M | $1M | $1M | $603.1K | $177.9K | $233.7K | $325.8K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $3M | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $951.8K | $905.3K | $2M | $2M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | · | $19M | $22M | $2M | |
| Intangibles | · | $0 | $0 | $12M | $12M | $13M | $13M | $14M | $39M | $15M | · | · | |
| Other Non-current Assets | $1M | $2M | $363.0K | $615.0K | $872.0K | $977.2K | $128.5K | $183.7K | $238.9K | $22.2K | $53.4K | $53.4K | |
| Total Assets | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Accounts Payable | $3M | $211.0K | $2M | $5M | $2M | $612.3K | $18.2K | $372.9K | $129.1K | $2M | $521.1K | $391.4K | |
| Accrued Liabilities | · | · | · | · | · | $11M | $4M | $4M | $4M | $3M | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $71.6K | $49.7K | $458.6K | · | · | |
| Current Liabilities | $15M | $10M | $12M | $17M | $18M | $12M | $4M | $5M | $4M | $5M | $2M | $3M | |
| Capital Leases | $1M | $1M | $175.0K | $672.0K | $1M | $1M | $1M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $58.5K | $6M | $442.6K | $380.8K | $319.0K | |
| Other Non-current Liabilities | $6M | $5M | $40.0K | $60.0K | $80.0K | $110.3K | $130.2K | $140.1K | $160.0K | $442.6K | $433.4K | $493.1K | |
| Total Liabilities | $55M | $16M | $17M | $22M | $20M | $19M | $9M | $6M | $14M | $6M | $3M | $4M | |
| Long-term Debt | $34M | · | · | · | · | · | · | $500.0K | $500.0K | $526.0K | · | · | |
| Total Debt | $34M | · | · | $5M | $1M | $2M | $2M | $71.6K | · | · | $0 | $746.1K | |
| Common Stock | $11.0K | $7.0K | $7.0K | $5.0K | $4.0K | $3.7K | $1.5K | $876 | $61 | $692 | $6.4K | $6.4K | |
| Paid-in Capital | $879M | $690M | $665M | $568M | $497M | $417M | $188M | $170M | $122M | $71M | $240M | $239M | |
| Retained Earnings | $-649M | $-561M | $-466M | $-378M | $-293M | $-186M | $-137M | $-117M | $-78M | $-31M | $-224M | $-220M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $0 | $-229.5K | |
| Stockholders' Equity | $225M | $124M | $194M | $185M | $199M | $226M | $46M | $48M | $39M | $32M | $43M | $18M | |
| Liabilities + Equity | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Shares Outstanding | 110,882,735 | 72,352,701 | 70,677,400 | 49,199,845 | 40,993,768 | 37,142,946 | 15,312,167 | 9,078,238 | 608,499 | 6,917,204 | 64,382,086 | 63,603,303 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $-205.0K | $551.0K | $428.9K | $387.3K | · | · | · | · | · | |
| Stock-based Comp | $16M | $14M | $11M | $8M | $6M | $3M | $1M | $773.2K | $1M | $965.4K | $613.0K | $2M | |
| Deferred Tax | $-681.0K | · | · | · | · | · | $-58.5K | $-6M | $-3M | $61.8K | $61.7K | $61.7K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| Other Non-cash | · | · | · | $14M | $13M | $12M | · | · | · | · | · | · | |
| Operating Cash Flow | $-68M | $-80M | $-76M | $-63M | $-78M | $-34M | $-10M | $-9M | $-20M | $-6M | $-3M | $-8M | |
| CapEx | $11.0K | · | $47.0K | $126.0K | $12M | $204.0K | $1.2K | $975.4K | $112.4K | $125.0K | $86.5K | $92.3K | |
| Investing Cash Flow | $-132M | $-28M | $14M | $-73M | $88M | $-72M | $-28M | $-1M | $14M | · | · | · | |
| Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Net Stock Activity | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Financing Cash Flow | $207M | $10M | $86M | $57M | $65M | $213M | $13M | $32M | $16M | · | · | · | |
| Net Change in Cash | $7M | $-98M | $24M | $-79M | $74M | $107M | $-25M | $22M | $9M | $138M | $-3M | $8M | |
| Free Cash Flow | $-68M | · | $-76M | $-63M | $-90M | $-35M | $-10M | $-10M | · | $201M | $-3M | $-9M | |
| Levered FCF | · | · | · | $-63M | · | $-35M | $-10M | $-11M | · | · | $-3M | $-9M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% | -669.5% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| Net Margin | -214861.0% | -475295.0% | -20762.2% | 124577.9% | -2201.4% | -599.2% | -353.7% | -379.2% | · | 115286.4% | · | · | |
| Pretax Margin | -216522.0% | -475295.0% | -20762.2% | 124867.7% | -2201.4% | -665.4% | -354.7% | -438.7% | · | 121929.0% | · | · | |
| EBITDA Margin | -230461.0% | -515860.0% | -22518.5% | 129330.9% | -2184.9% | -665.9% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| ROA | -42.0% | -54.3% | -42.4% | -39.8% | -41.9% | -32.8% | -37.7% | -66.5% | · | 158.5% | -16.4% | -50.9% | |
| ROE | -45.6% | -74.0% | -51.3% | -43.4% | -47.5% | -23.1% | -43.2% | -89.0% | · | 619.4% | -19.7% | -77.8% | |
| ROIC | -36.2% | · | · | -46.1% | · | -21.7% | -45.2% | -76.5% | · | -54.7% | -20.8% | -53.9% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 | 19.2 | 10.0 | 8.7 | · | 1.1 | 7.9 | 7.5 | |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 | 18.0 | 9.5 | 7.4 | · | 1.1 | 7.1 | 7.4 | |
| Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -2740.8 | -10967.5 | -17134.7 | -5816.7 | -9565.5 | -144.2 | · | · | -62.3 | -48.4 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.1 | 0.1 | 0.2 | · | 0.0 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.03 | $1.71 | $2.75 | $3.77 | $4.86 | $6.08 | $2.97 | $5.32 | · | $0.29 | $0.26 | $0.29 | |
| Revenue / Share | $0.00 | $0.00 | $0.01 | $-0.00 | $0.11 | · | · | · | · | $0.00 | · | · | |
| Cash Flow / Share | $-0.77 | $-1.12 | $-1.42 | $-1.33 | $-1.90 | · | · | · | · | $3.07 | · | · | |
| Cash / Share | $0.39 | $0.51 | $1.91 | $2.26 | $4.64 | $3.12 | $0.59 | $3.71 | · | $2.27 | $0.24 | $0.29 | |
| EPS (TTM) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | $2.92 | $2.92 | $2.92 | $2.95 | $-0.05 | $-0.17 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 105.0% | -95.3% | · | · | -46.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -83.5% | -62.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -65.3% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| Net Income TTM | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| Market Cap | $400M | $522M | $795M | $809M | $376M | $419M | $29M | $19M | · | · | · | · | |
| Enterprise Value | $161M | · | · | $629M | $187M | $205M | $-6M | $-15M | · | · | · | · | |
| P/E | -3.6 | -5.4 | -6.8 | -9.1 | -3.9 | -5.9 | 0.6 | 0.7 | 20.4 | · | · | · | |
| P/S | 9763.1 | 26083.1 | 1866.5 | -11902.0 | 85.1 | 51.2 | 5.0 | 1.8 | · | · | · | · | |
| P/B | 1.8 | 4.2 | 4.1 | 4.4 | 1.9 | 1.9 | 0.6 | 0.4 | · | · | · | · | |
| P / Tangible Book | 1.8 | 4.2 | 4.1 | 4.7 | 2.0 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -6.5 | -10.5 | -12.9 | -4.8 | -12.2 | -3.0 | -2.0 | · | · | · | · | |
| P / FCF | -5.9 | · | -10.5 | -12.9 | -4.2 | -12.1 | -3.0 | -1.8 | · | · | · | · | |
| EV / EBITDA | -1.7 | · | · | -7.2 | -1.9 | -3.8 | 0.3 | 0.3 | · | · | · | · | |
| EV / FCF | -2.4 | · | · | -10.0 | -2.1 | -5.9 | 0.7 | 1.4 | · | · | · | · | |
| EV / Revenue | 3929.7 | · | · | -9250.6 | 42.3 | 25.0 | -1.1 | -1.4 | · | · | · | · | |
| Earnings Yield | -27.7% | -18.6% | -14.8% | -11.0% | -25.7% | -16.9% | 154.5% | 141.8% | 4.9% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $26.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $37.0K | $362.0K | $6.0K | $21.0K | $-110.0K | $2.0K | |
| R&D Expense | $19M | $16M | $18M | $15M | $17M | $16M | $20M | $20M | $21M | $21M | $17M | $18M | $13M | $17M | $19M | $20M | |
| SG&A Expense | $8M | $8M | $11M | $6M | $6M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | $5M | $5M | $4M | $4M | |
| Operating Expenses | $26M | $24M | $29M | $21M | $23M | $22M | $25M | $25M | $27M | $27M | $34M | $23M | $18M | $22M | $23M | $25M | |
| Operating Income | $-26M | $-24M | $-29M | $-21M | $-23M | $-22M | $-25M | $-25M | $-27M | $-27M | $-34M | $-23M | $-18M | $-22M | $-23M | $-25M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1.0K | · | $29.0K | $2.0K | $2.0K | $-183.0K | $64.0K | |
| Interest Income | $5M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-op | $-25.0K | $-152.0K | $-27.0K | $-86.0K | $-92.0K | $15.0K | $118.0K | $18.0K | $-76.0K | $-12.0K | $20.0K | $14.0K | $113.0K | $19.0K | $-217.0K | $50.0K | |
| Pretax Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | · | · | $-22M | $-24M | |
| Income Tax | · | · | $0 | $0 | $0 | $-681.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $-197.0K | |
| Net Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | $-16M | $-20M | $-22M | $-24M | |
| EPS (Basic) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| EPS (Diluted) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| Shares (Basic) | 185,443,736 | 124,461,818 | · | 89,418,028 | 81,477,548 | 75,547,746 | · | 71,084,787 | 70,924,371 | 70,801,713 | · | 53,633,354 | 50,691,558 | 50,125,685 | · | 49,286,535 | |
| Shares (Diluted) | 185,443,736 | 124,461,818 | · | 89,418,028 | 81,477,548 | 75,547,746 | · | 71,084,787 | 70,924,371 | 70,801,713 | · | 53,633,354 | 50,691,558 | 50,125,685 | · | 49,286,535 | |
| EBITDA | $-26M | $-24M | · | $-21M | $-23M | $-22M | · | $-25M | $-27M | $-27M | · | $-23M | $-18M | $-22M | · | $-25M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $98M | $44M | $61M | $183M | $49M | $37M | $31M | $57M | $79M | $135M | $87M | $102M | $105M | $111M | $127M | |
| Short-term Investments | $263M | $234M | $230M | $150M | · | $101M | $95M | $108M | $108M | $103M | $63M | $54M | $58M | $61M | $74M | $74M | |
| Prepaid Expense | $5M | $1M | $3M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $7M | $8M | $6M | $4M | $5M | $5M | |
| Current Assets | $335M | $335M | $278M | $217M | $188M | $155M | $137M | $146M | $171M | $188M | $210M | $153M | $170M | $173M | $193M | $211M | |
| PP&E (Net) | $60.0K | $208.0K | $312.0K | $337.0K | $364.0K | $384.0K | $413.0K | $446.0K | $483.0K | $544.0K | $651.0K | $765.0K | $882.0K | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | $12M | |
| Other Non-current Assets | $90.0K | $746.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $299.0K | $363.0K | $425.0K | $483.0K | $546.0K | $615.0K | $682.0K | |
| Total Assets | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Accounts Payable | $1M | $2M | $3M | $5M | $851.0K | $1M | $211.0K | $1M | $3M | $4M | $2M | $3M | $4M | $5M | $5M | $1M | |
| Current Liabilities | $13M | $11M | $15M | $13M | $9M | $10M | $10M | $9M | $15M | $11M | $12M | $12M | $11M | $15M | $17M | $16M | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $44.0K | $175.0K | $303.0K | $429.0K | $552.0K | $672.0K | $788.0K | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $5M | $16.0K | $5M | $26.0K | $31.0K | $37.0K | $40.0K | $46.0K | $52.0K | $56.0K | $60.0K | $66.0K | |
| Total Liabilities | $53M | $52M | $55M | $33M | $29M | $15M | $16M | $14M | $21M | $15M | $17M | $16M | $16M | $19M | $22M | $20M | |
| Long-term Debt | $35M | $35M | $34M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $35M | $35M | · | $14M | $14M | · | · | · | · | · | · | $4M | $4M | $4M | · | $5M | |
| Common Stock | $19.0K | $13.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $1.18B | $961M | $879M | $813M | $770M | $728M | $690M | $676M | $673M | $669M | $665M | $590M | $587M | $571M | $568M | $567M | |
| Retained Earnings | $-695M | $-672M | $-649M | $-622M | $-603M | $-581M | $-561M | $-538M | $-515M | $-491M | $-466M | $-435M | $-414M | $-398M | $-378M | $-356M | |
| AOCI | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $474M | $284M | $225M | $186M | $161M | $142M | $124M | $133M | $153M | $173M | $194M | $150M | $168M | $168M | $185M | $205M | |
| Liabilities + Equity | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Shares Outstanding | 194,474,154 | 130,221,154 | 110,882,735 | 95,598,665 | 85,076,300 | 77,825,450 | 72,352,701 | 71,124,407 | 71,046,267 | 70,899,134 | 70,677,400 | 52,858,920 | 52,657,661 | 49,286,710 | 49,199,845 | 49,161,637 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $-552.0K | $-505.0K | $-356.0K | · | $-141.0K | |
| Stock-based Comp | $3M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $-681.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-19M | $-12M | $-19M | $-17M | $-18M | $-27M | $-18M | $-16M | $-17M | $-20M | $-19M | $-19M | $-17M | $-15M | |
| CapEx | $32.0K | $21.0K | $1.0K | $0 | · | · | · | · | · | · | $0 | $0 | $-4.0K | $51.0K | $38.0K | $60.0K | |
| Investing Cash Flow | $-221M | $-4M | $-79M | $-149M | $101M | $-5M | $14M | $1M | $-4M | $-40M | $-8M | $4M | $4M | $13M | $981.0K | $-25M | |
| Debt Issued | · | · | $20M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $-89.0K | $9M | $62M | $40M | $38M | $35M | · | · | · | · | $73M | $510.0K | · | · | $0 | $32M | |
| Net Stock Activity | · | $9M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $211M | $78M | $81M | $39M | $52M | $34M | $10M | $266.0K | $-46.0K | $-261.0K | $73M | $588.0K | $13M | $-302.0K | $-43.0K | $32M | |
| Net Change in Cash | $-35M | $54M | $-17M | $-122M | $134M | $12M | $5M | $-26M | $-22M | $-56M | $48M | $-15M | $-2M | $-6M | $-16M | $-8M | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | · | · | · | · | $-19M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -103614.3% | · | -1237600.0% | |
| Net Margin | · | · | · | -380280.0% | -442920.0% | -391500.0% | · | -456900.0% | -492800.0% | -487880.0% | · | -5710.2% | -267683.3% | -95590.5% | · | -1175800.0% | |
| Pretax Margin | · | · | · | -380280.0% | -442920.0% | -405120.0% | · | · | · | · | · | -5710.2% | · | · | · | -1185650.0% | |
| EBITDA Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -105309.5% | · | -1237600.0% | |
| ROA | -6.4% | -9.2% | · | -10.4% | -12.2% | -11.3% | · | -14.5% | -13.8% | -13.0% | · | -10.5% | -8.2% | -10.2% | · | -10.2% | |
| ROE | -7.2% | -10.6% | · | -11.9% | -14.1% | -12.4% | · | -16.1% | -15.4% | -14.3% | · | -11.6% | -8.9% | -11.4% | · | -11.3% | |
| ROIC | · | · | · | · | · | -14.8% | · | · | · | · | · | · | · | · | · | -11.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.8 | 29.6 | · | 17.2 | 20.4 | 15.8 | · | 16.9 | 11.3 | 16.5 | · | 12.9 | 14.8 | 11.6 | · | 13.4 | |
| Quick Ratio | 26.1 | 29.3 | · | 16.7 | 19.9 | 15.3 | · | 16.1 | 10.9 | 16.1 | · | 11.9 | 14.0 | 11.1 | · | 12.8 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -26794.0 | · | -777.2 | -9003.5 | -10879.5 | · | -386.8 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.44 | $2.18 | · | $1.94 | $1.90 | $1.83 | · | $1.88 | $2.15 | $2.44 | · | $2.85 | $3.19 | $3.40 | · | $4.17 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.22 | · | · | · | $-0.23 | · | · | · | $-0.39 | · | · | |
| Cash / Share | $0.32 | $0.75 | · | $0.64 | $2.15 | $0.63 | · | $0.44 | $0.80 | $1.11 | · | $1.64 | $1.94 | $2.12 | · | $2.59 | |
| EPS (TTM) | $-0.77 | $-0.92 | · | $-1.07 | $-1.18 | $-1.26 | · | $-1.56 | $-1.63 | $-1.60 | · | $-1.58 | $-1.67 | $-1.77 | · | $-1.90 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41.0K | $41.0K | · | $20.0K | $20.0K | $20.0K | · | $52.0K | $409.0K | $410.0K | · | $279.0K | $-81.0K | $-79.0K | · | $3M | |
| Net Income TTM | $-92M | $-91M | · | $-84M | $-88M | $-90M | · | $-104M | $-101M | $-93M | · | $-78M | $-81M | $-85M | · | $-87M | |
| Market Cap | $591M | $401M | · | $360M | $329M | $389M | · | $437M | $472M | $722M | · | $137M | $186M | $208M | · | $628M | |
| Enterprise Value | $300M | $104M | · | $164M | $160M | · | · | · | · | · | · | $959.2K | $30M | $47M | · | $430M | |
| P/E | -3.9 | -3.3 | · | -3.5 | -3.3 | -4.0 | · | -3.9 | -4.1 | -6.4 | · | -1.6 | -2.1 | -2.4 | · | -6.7 | |
| P/S | 14419.5 | 9782.5 | · | 18020.3 | 16462.3 | 19456.4 | · | 8398.2 | 1155.2 | 1760.4 | · | 492.6 | -2294.8 | -2632.8 | · | 189.2 | |
| P/B | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.1 | |
| P / Tangible Book | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.3 | |
| P / Cash Flow | · | -19.2 | · | · | · | -23.1 | · | · | · | -44.1 | · | · | · | -10.7 | · | · | |
| EV / Revenue | 7308.8 | 2537.7 | · | 8203.8 | 8023.6 | · | · | · | · | · | · | 3.4 | -371.5 | -590.6 | · | 129.7 | |
| Earnings Yield | -25.3% | -29.9% | · | -28.4% | -30.5% | -25.2% | · | -25.4% | -24.5% | -15.7% | · | -60.8% | -47.3% | -41.9% | · | -14.9% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $41.0K | $20.0K | $426.0K | $-68.0K | $4M |
| Margine Operativo % | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% |
| Utile netto | $-88M | $-95M | $-88M | $-85M | $-97M |
| EPS Diluito | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.2 | · | · | 0.0 | 0.0 |
| Rapporto corrente | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-68M | · | $-76M | $-63M | $-90M |
Proprietari istituzionali (13F) 235 filer · $501.0M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
235
Valore detenuto
$501.0M
Nuove posizioni
61
Posizioni chiuse
17
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 61 (+31 vs trimestre precedente) | 17 (-16 vs trimestre precedente) | 87 (+3 vs trimestre precedente) | 37 (-2 vs trimestre precedente) | +81.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $61.971.264 | 20.385.284 | 12,37% | Azioni |
| Deep Track Capital, LP | $58.520.000 | 19.250.000 | 11,68% | Azioni |
| STATE STREET CORP | $36.779.562 | 12.098.540 | 7,34% | Azioni |
| VANGUARD GROUP INC | $34.263.084 | 9.491.159 | 6,84% | Azioni |
| TCG Crossover Management, LLC | $30.400.000 | 10.000.000 | 6,07% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.860.366 | 8.177.752 | 4,96% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.284.006 | 7.330.265 | 4,45% | Azioni |
| MARSHALL WACE, LLP | $20.796.808 | 6.841.055 | 4,15% | Azioni |
| VIKING GLOBAL INVESTORS LP | $20.368.000 | 6.700.000 | 4,07% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $19.760.000 | 6.500.000 | 3,94% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $15.238.163 | 5.011.314 | 3,04% | Azioni |
| Woodline Partners LP | $10.336.948 | 3.400.312 | 2,06% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $10.059.731 | 3.309.122 | 2,01% | Azioni |
| Trails Edge Capital Partners, LP | $8.086.400 | 2.660.000 | 1,61% | Azioni |
| Nuveen, LLC | $7.312.276 | 2.405.354 | 1,46% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $7.238.672 | 2.381.142 | 1,44% | Azioni |
| GOLDMAN SACHS GROUP INC | $6.731.928 | 2.214.450 | 1,34% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.469.872 | 1.799.300 | 1,09% | Opzione Call |
| GREAT POINT PARTNERS LLC | $5.293.345 | 1.741.232 | 1,06% | Azioni |
| NORTHERN TRUST CORP | $4.861.648 | 1.599.226 | 0,97% | Azioni |
| Weiss Asset Management LP | $4.653.641 | 1.530.803 | 0,93% | Azioni |
| Nantahala Capital Management, LLC | $4.560.000 | 1.500.000 | 0,91% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $3.930.723 | 1.293.001 | 0,78% | Azioni |
| Cormorant Asset Management, LP | $3.800.000 | 1.250.000 | 0,76% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $3.711.686 | 1.220.949 | 0,74% | Azioni |
| CITADEL ADVISORS LLC | $2.990.019 | 983.559 | 0,60% | Azioni |
| TWO SIGMA ADVISERS, LP | $2.865.979 | 793.900 | 0,57% | Azioni |
| UBS Group AG | $2.633.810 | 866.385 | 0,53% | Azioni |
| MORGAN STANLEY | $2.305.642 | 758.435 | 0,46% | Azioni |
| BANK OF AMERICA CORP /DE/ | $2.304.074 | 757.919 | 0,46% | Azioni |
| Ghisallo Capital Management LLC | $2.280.000 | 750.000 | 0,46% | Azioni |
| FMR LLC | $2.276.881 | 748.974 | 0,45% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.222.477 | 731.078 | 0,44% | Azioni |
| Bank of New York Mellon Corp | $2.096.727 | 689.713 | 0,42% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $2.024.707 | 666.022 | 0,40% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.943.537 | 639.436 | 0,39% | Azioni |
| CITADEL ADVISORS LLC | $1.918.240 | 631.000 | 0,38% | Opzione Call |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.898.477 | 624.499 | 0,38% | Azioni |
| Point72 Asset Management, L.P. | $1.480.127 | 486.884 | 0,30% | Azioni |
| Rock Springs Capital Management LP | $1.433.254 | 471.465 | 0,29% | Azioni |
| Beirne Wealth Consulting Services, LLC | $1.282.449 | 421.858 | 0,26% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.277.712 | 420.300 | 0,26% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $1.128.375 | 371.176 | 0,23% | Azioni |
| BARCLAYS PLC | $1.068.825 | 351.587 | 0,21% | Azioni |
| Invesco Ltd. | $1.011.079 | 332.592 | 0,20% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $990.128 | 325.700 | 0,20% | Opzione Put |
| RHUMBLINE ADVISERS | $941.193 | 309.606 | 0,19% | Azioni |
| LMR Partners LLP | $912.000 | 300.000 | 0,18% | Azioni |
| CITIGROUP INC | $893.602 | 293.948 | 0,18% | Azioni |
| Steward Partners Investment Advisory, LLC | $810.680 | 266.671 | 0,16% | Azioni |
Attivisti e proprietari del 5%+ 18 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Shah, Nimish, Koh, Bong | 25 Giugno 2020 | · | Deposito iniziale | Investimento passivo | SEC |
| Philip Hodges, Redmont Venture Partners, Inc., Redmont VAXN Capital Holdings, LLC, Paradigm Venture Partners, L.P. ×3 depositi | 19 Ottobre 2017 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 30 Marzo 2016 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 12 Febbraio 2016 | · | Deposito iniziale | · | SEC |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., PRESCOTT GROUP AGGRESSIVE SMALL CAP, L.P., PRESCOTT GROUP AGGRESSIVE SMALL CAP II, L.P., PHIL FROHLICH ×6 depositi | 02 Dicembre 2013 | · | Deposito iniziale | Investimento passivo | SEC |
| Theraclone Sciences, Inc. | 12 Agosto 2013 | · | Deposito iniziale | M&A / vendita | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 27 Dicembre 2010 | · | Deposito iniziale | Investimento passivo | SEC |
| Kelisia Holdings L imited, Panacea Biotec Limited | 18 Settembre 2009 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 04 Agosto 2009 | · | Deposito iniziale | Investimento passivo | SEC |
| HealthCare Ventures VII, L.P., HealthCare Partners VII, L.P., James H. Cavanaugh, Ph.D., John Littlechild, Harold Werner, Augustine Lawlor, Christopher Mirabelli, Ph.D. ×3 depositi | 03 Agosto 2009 | · | Deposito iniziale | Investimento passivo | SEC |
| Bear Stearns Health Innoventures, L.P., Bear Stearns Health Innoventures Offshore, L.P., BX, L.P., Bear Stearns Health Innoventures Employee Fund, L.P., BSHI Members, L.L.C., Bear Stearns Health Innoventures Management, L.L.C., Bear Stearns Asset Management Inc. ×3 depositi | 29 Maggio 2009 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| Integrated Core Strategies (US) LLC, Riverview Group LLC, Millennium Management LLC, Israel A. Englander ×2 depositi | 23 Aprile 2009 | · | Deposito iniziale | M&A / vendita | SEC |
| Nexia Biotechnologies Ltd. | 30 Maggio 2008 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 17 Agosto 2007 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 14 Agosto 2007 | · | Deposito iniziale | Investimento passivo | SEC |
| MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM BioVentures III Parallel Fund, L.P., MPM Asset Management Investors 2004 BVIII LLC, MPM BioVentures III GP, L.P., MPM BioVentures III LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz, Kurt Wheeler | 14 Agosto 2007 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata | 13 Agosto 2007 | · | Deposito iniziale | M&A / vendita | SEC |
| QVT Financial LP, QVT Financial GP LLC ×2 depositi | 07 Agosto 2007 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 49 insider · 26 dirigenti · 21 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jerome Benedict Durso | President and CEO | 13 Agosto 2026 P | 62.500 | 4 | 0 | $213.775 |
| William Enright | President and CEO | 25 Maggio 2018 P | 365.839 | 0 | 0 | $0 |
| David P Wright | President and CEO | 11 Dicembre 2009 P | 399.500 | 0 | 0 | $0 |
| Gregory L Weaver | Chief Financial Officer | 31 Luglio 2026 A | 39.831 | 2 | 0 | $49.200 |
| Andrew Shutterly | Acting Chief Financial Officer | 31 Luglio 2024 A | 11.372 | 0 | 0 | $0 |
| Richard I Eisenstadt | Chief Financial Officer | 30 Gennaio 2024 M | 45.012 | 0 | 0 | $0 |
| William Michael Brown | Chief Financial Officer | 31 Luglio 2021 A | 17.721 | 0 | 0 | $0 |
| Elizabeth Czerepak | CFO and EVP Corp. Development | 22 Settembre 2017 A | · | 0 | 0 | $0 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 21 Dicembre 2016 M | 126.346 | 0 | 0 | $0 |
| Linda L Chang | SVP, CFO & Secretary | 07 Gennaio 2015 M | 30.000 | 0 | 0 | $0 |
| Charles A. Reinhart III | SVP, Chief Financial Officer | 08 Dicembre 2010 A | · | 0 | 0 | $0 |
| Kevin Price | President - PharmAthene UK,Ltd | 21 Gennaio 2009 A | 2.500 | 0 | 0 | $0 |
| Jeffrey Michael Jones | COO | 11 Marzo 2015 A | 27.544 | 0 | 0 | $0 |
| Richard Thomas Menziuso | Principal Accounting Officer | 01 Ottobre 2026 A | · | 0 | 0 | $0 |
| Linda M Richardson | Chief Commercial Officer | 16 Settembre 2026 M | 17.174 | 0 | 0 | $0 |
| Scot M Roberts | Chief Scientific Officer | 31 Luglio 2026 A | 113.699 | 0 | 0 | $0 |
| Raymond M Jordt | Chief Business Officer | 31 Gennaio 2026 A | 70.107 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 01 Ottobre 2025 A | · | 0 | 0 | $0 |
| Matthew Scott Harris | Chief Medical Officer | 31 Luglio 2025 A | 16.087 | 0 | 0 | $0 |
| Sybil Tasker | Chief Medical Officer | 17 Giugno 2019 A | · | 0 | 0 | $0 |
| Wayne Morges | SVP, Reg. Affairs & Quality | 08 Dicembre 2014 A | 35.532 | 0 | 0 | $0 |
| Francesca M Cook | SVP, Policy & Gov't Affairs | 08 Dicembre 2014 A | 37.631 | 0 | 0 | $0 |
| Thomas Richard Fuerst | EVP, Chief Scientific Officer | 01 Dicembre 2011 A | 15.000 | 0 | 0 | $0 |
| Valerie D Riddle | SVP, Medical Director | 31 Maggio 2011 M | 44.436 | 0 | 0 | $0 |
| Joan Fusco | SVP, Operations | 06 Maggio 2010 A | 36.730 | 0 | 0 | $0 |
| Christopher C Camut | VP, Gov't Contracts | 21 Gennaio 2010 F | 46.777 | 0 | 0 | $0 |
| Teri L Lawver | Direttore | 01 Maggio 2026 A | · | 0 | 0 | $0 |
| Wayne Pisano | Direttore | 01 Maggio 2026 A | 13.498 | 1 | 0 | $20.400 |
| Klaus Schafer | Direttore | 01 Maggio 2026 A | 9.179 | 0 | 0 | $0 |
| Philip Hodges | Direttore | 01 Maggio 2026 A | 8.731 | 0 | 0 | $0 |
| Catherine A. Sohn | Direttore | 01 Maggio 2026 A | 1.500 | 1 | 0 | $2.120 |
| Diane Jorkasky | Direttore | 01 Maggio 2026 A | 527 | 1 | 0 | $2.003 |
| John Gill | Direttore | 01 Maggio 2026 A | 21.700 | 2 | 0 | $82.622 |
| Mitchel Sayare | Direttore | 01 Maggio 2026 A | 26.363 | 0 | 0 | $0 |
| Vipin K Garg | Direttore | 30 Gennaio 2026 M | 424.519 | 0 | 0 | $0 |
| David Drutz | Direttore | 19 Agosto 2024 M | 55.524 | 0 | 0 | $0 |
| SCHAFFER DERACE L | Direttore | 29 Dicembre 2017 P | 589.453 | 0 | 0 | $0 |
| Jeffrey W. Runge | Direttore | 20 Gennaio 2017 M | 197.700 | 0 | 0 | $0 |
| Steven St Peter | Direttore | 04 Gennaio 2017 M | 205.004 | 0 | 0 | $0 |
| Eric I Richman | Direttore | 22 Novembre 2016 M | 898.055 | 0 | 0 | $0 |
| Joel Mccleary | Direttore | 31 Dicembre 2014 A | 120.167 | 0 | 0 | $0 |
| Brian A Markison | Direttore | 31 Dicembre 2014 A | · | 0 | 0 | $0 |
| John Pappajohn | Direttore | 23 Giugno 2011 A | 394.044 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Direttore | 23 Giugno 2010 A | · | 0 | 0 | $0 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | Proprietario del 10% | 15 Maggio 2020 S | 1.687.250 | 0 | 0 | $0 |
| Truffle Capital S.A.S. | Proprietario del 10% | 13 Febbraio 2018 J | 76.700 | 0 | 0 | $0 |
| ANSBERT GADICKE | Proprietario del 10% | 03 Agosto 2007 A | · | 0 | 0 | $0 |
| Jordan P Karp | · | 03 Dicembre 2012 A | 21.929 | 0 | 0 | $0 |
| Matthew P Kinley | · | 03 Agosto 2007 P | 541.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 24 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,73% | 119.086 NS | 31 Luglio 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,46% | 38.580 SH | 02 Ottobre 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,16% | 275.123 NS | 31 Luglio 2026 | N-PORT |
| IWC · iShares Trust | 0,15% | 673.707 SH | 11 Settembre 2026 | Giornaliero |
| IBB · iShares Trust | 0,05% | 1.414.762 SH | 11 Settembre 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,04% | 3.759 NS | 31 Luglio 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 172.834 SH | 19 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 13.762 SH | 02 Ottobre 2026 | Giornaliero |
| IWM · iShares Trust | 0,02% | 5.067.516 SH | 11 Settembre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 202.880 SH | 02 Ottobre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.142.675 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,02% | 94.969 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.235.429 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 569.267 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 167.692 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 358.632 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,00% | 8.167 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.537 SH | 03 Settembre 2026 | Giornaliero |
| DFUS · Dimensional ETF Trust | 0,00% | 25.408 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9.653 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 34.439 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.748.771 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 16.865 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 1.858.292 SH | 11 Settembre 2026 | Giornaliero |
ALT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 15 analisti
COMPRA
Target mediano
$17.00
+521,6%
4 26,7%
Acquisto forte
9 60,0%
Compra
2 13,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
9 analisti · 2026-09-30Target medio $17.11 +525,6%
← Sotto tutti i target
Prezzo attuale $2.73
Basso$11.00
Media$17.11
Alto$28.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| MNPR | · | · | · | · | · | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
Ultime notizie Notizie recenti che menzionano questa società
Ecco perché Altimmune Inc. (ALT) sembra essere un penny stock attraente
Yahoo Finance · 5 mesi fa
Azioni Altimmune Approvano Tutti i Proposte dell'AGM, Aumentando le Azioni Autorizzate a 400M
Yahoo Finance · 5 mesi, 2 settimane fa
Venerdì 4/10 Rapporto sugli Acquisti da Parte di Insider: CNXC, ALT
Nasdaq · 5 mesi, 3 settimane fa
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 12, 2026